This is a standard proxy filing. Monitor the company's website or future filings for the full proxy statement (DEF 14A) to see the specific voting items, such as director nominees and executive pay proposals, ahead of the shareholder meeting.
Price Chart
Executive Summary
Regeneron Pharmaceuticals has filed definitive additional proxy soliciting materials (DEFA14A) with the SEC. This is a routine filing related to an upcoming shareholder vote, likely covering items such as director elections, executive compensation, or other corporate governance matters. The filing is from the registrant and is definitive, indicating that the final details for the vote have been provided to shareholders. There is no indication of activist involvement or contentious issues.
Key Facts
- Company: Regeneron Pharmaceuticals, Inc. (REGN)
- Form Type: DEFA14A (Definitive Additional Proxy Soliciting Materials)
- Filing Status: Filed by the Registrant, Definitive
- No activist involvement (SC 13D) or dissident campaign indicated
- Filing is routine and administrative in nature
Financial Impact
No direct financial impact from this filing
Risk Factors
- None identified from this specific filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001308179-26-000341 |
| Document: 0001308179-26-000341-index-headers.html | 0001308179-26-000341 |
| Document: 0001308179-26-000341-index.html | 0001308179-26-000341 |
| Document: 0001308179-26-000341.txt | 0001308179-26-000341 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 1d ago | ANALYST-UPGRADE | — | awaiting T+5 | — | — |
Sep 3, 2026 29d ago | Insider Cluster | $843.47 $781.49 | ▼ −7.35% | ▼ −6.20% | $735.20 (−12.84%) |
Aug 24, 2026 5w ago | Court Ruling | $828.50 $799.08 | ▼ −3.55% | ▼ −4.02% | $735.20 (−11.26%) |
Aug 20, 2026 6w ago | Press Release | $826.64 $807.71 | ▼ −2.29% | ▼ −3.40% | $735.20 (−11.06%) |
Aug 12, 2026 7w ago | Insider Cluster | $797.99 $840.84 | ▲ +5.37% | ▲ +5.81% | $735.20 (−7.87%) |
Aug 11, 2026 7w ago | Court Ruling | $797.00 $807.57 | ▲ +1.33% | ▲ +1.73% | $735.20 (−7.75%) |
Jul 30, 2026 9w ago | 8-K | $738.34 $772.11 | ▲ +4.57% | ▲ +0.95% | $735.20 (−0.43%) |
Jul 30, 2026 9w ago | Press Release | $738.34 $772.11 | ▲ +4.57% | ▲ +0.95% | $735.20 (−0.43%) |
Jul 27, 2026 9w ago | Press Release | $695.18 $759.24 | ▼ −9.21% | ▼ −6.95% | $735.20 (−5.76%) |
Jul 17, 2026 11w ago | Press Release | $676.69 $651.91 | ▼ −3.66% | ▼ −2.97% | $735.20 (+8.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access